Antithrombotic therapy before, during and after transcatheter aortic valve replacement (TAVR).
J Thromb Thrombolysis
; 39(4): 467-73, 2015 May.
Article
em En
| MEDLINE
| ID: mdl-25103613
ABSTRACT
Transcatheter aortic valve replacement (TAVR) has been emerged as a promising alternative for the management of patients with severe AS who otherwise are deemed inappropriate candidates for surgery. Post procedural thromboembolic events and risk of bleeding continue to be a significant challenge in managing patients who underwent TAVR. This article systematically reviews the evidence, current guidelines and upcoming studies investigating antithrombotic therapy before, during and after TAVR.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Estenose da Valva Aórtica
/
Assistência Perioperatória
/
Fibrinolíticos
/
Substituição da Valva Aórtica Transcateter
Tipo de estudo:
Guideline
Limite:
Humans
Idioma:
En
Revista:
J Thromb Thrombolysis
Assunto da revista:
ANGIOLOGIA
Ano de publicação:
2015
Tipo de documento:
Article